![Daniel Ritz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profilo
Daniel Ritz is currently Chief Scientific Officer at BioVersys AG since 2025.
Dr. Ritz was Head-Biology Technologies & Discovery at Idorsia Pharmaceuticals Ltd.
Posizioni attive di Daniel Ritz
| Società | Posizione | Inizio |
|---|---|---|
| BIOVERSYS AG | Direttore Tecnico/Scientifico/R&S | 03/11/2025 |
Precedenti posizioni note di Daniel Ritz
| Società | Posizione | Fine |
|---|---|---|
Idorsia Pharmaceuticals Ltd.
 Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Corporate Officer/Principal | 01/01/2025 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
1
Relazioni di 1° grado
2
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
BioVersys AG
 BioVersys AG BiotechnologyHealth Technology Engages in research and development of small molecules on novel bacterial targets with application of AMR & antibiotic drugs | Health Technology |
Idorsia Pharmaceuticals Ltd.
Idorsia Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals | Health Technology |
